Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024

CERT 10.09.2024

Full Press ReleaseSEC FilingsOur CERT Tweets

About Gravity Analytica

Recent News

  • 01.16.2025 - 43rd Annual J.P. Morgan Healthcare Conference
  • 01.15.2025 - Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
  • 01.02.2025 - Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Recent Filings

  • 01.15.2025 - 8-K Current report
  • 12.16.2024 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
  • 11.13.2024 - SC 13G Statement of Beneficial Ownership by Certain Investors
PDF Version

RADNOR, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the third quarter of 2024 after the market close on Wednesday, November 6th, 2024. Company management will host a conference call to discuss financial results at 5:00PM ET.

Investors interested in listening to the conference call are required toregister online. It is recommended to register at least one day in advance.

A live and archived webcast of the event will be available on the “Investors” section of the Certara website athttps://ir.certara.com/.

About CertaraCertara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.

Investor Relations Contact:David DeuchlerGilmartin Groupir@certara.com

Media Contact:Alyssa Horowitzcertara@pancomm.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com